Recombinant Human MARCKSL1 Protein，His

MARCKSL1 (myristoylated alanine-rich C kinase substrate-like protein 1) is a member of the MARCKS family of proteins, which are implicated in various cellular processes, including cytoskeletal organization, signal transduction, and membrane dynamics. Research has shown that MARCKSL1 plays a crucial role in modulating immune responses and cell adhesion, making it significant in the fields of immunology and cancer biology. Its myristoylation, a post-translational modification, facilitates its interaction with cellular membranes, influencing actin filament assembly and cellular motility. Recent studies have highlighted MARCKSL1's involvement in the modulation of inflammatory responses, particularly in macrophages, suggesting that it may play a role in autoimmune diseases and infections. Moreover, alterations in MARCKSL1 expression have been linked to various cancers, indicating its potential as a biomarker or therapeutic target. Understanding the molecular mechanisms underlying MARCKSL1 function and regulation is essential for elucidating its contribution to disease processes and developing novel therapeutic strategies. Thus, the recombinant protein of MARCKSL1 is increasingly being utilized in research to explore its functional roles, interactions, and potential applications in targeted therapies. As the scientific community continues to investigate the full-spectrum roles of MARCKSL1, it remains a promising candidate for further study in both basic and translational research settings.